“…Medical diagnosis of early form of disease relies on the effective quantitative detection of patient biomarkers, so various testing technologies, such as enzyme-linked immunosorbent assay (ELISA) [12] , [13] , surface plasmon resonance (SPR) [14] , [15] and fluorescence analysis [16] , have been widely employed in disease diagnosis. Among numerous analytic methods, electrochemiluminescent (ECL) [17] , [18] , [19] and colorimetric [20] , [21] methods hold promise for achieving sensitive, widespread and facile disease diagnosis due to their high selectivity and high noise-to-signal.…”